GB Patent

GB8821287D0 — Device

Assigned to Imperial Chemical Industries Ltd · Expires 1988-10-12 · 38y expired

What this patent protects

Patent listed against Remodulin.

Drugs covered by this patent

Remodulin (TREPROSTINIL) · United Therap

Patent Metadata

Patent number: GB8821287D0
Jurisdiction: GB
Classification: —
Expires: 1988-10-12
Drug substance claim: No
Drug product claim: No
Assignee: Imperial Chemical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.